Application of a Microreactor to Pharmaceutical Manufacturing: Preparation of Amorphous Curcumin Nanoparticles and Controlling the Crystallinity of Curcumin Nanoparticles by Ultrasonic Treatment

被引:12
作者
Araki, Kaeko [1 ]
Yoshizumi, Mai [1 ]
Kimura, Shunsuke [2 ]
Tanaka, Akiko [3 ]
Inoue, Daisuke [4 ]
Furubayashi, Tomoyuki [3 ]
Sakane, Toshiyasu [3 ]
Enomura, Masakazu [1 ]
机构
[1] M Tech Co Ltd, 2-2-16 Technostage, Izumi, Osaka 5941144, Japan
[2] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Pharmaceut, Kyotanabe, Kyoto, Japan
[3] Kobe Pharmaceut Univ, Lab Pharmaceut Technol, Kobe, Hyogo, Japan
[4] Shujitsu Univ, Sch Pharm, Okayama, Japan
关键词
microreactor; curcumin; nanoparticle; amorphous; crystallinity; SOLUBILITY; DRUG; CYCLODEXTRINS; DISSOLUTION; STRATEGIES; PARTICLES;
D O I
10.1208/s12249-019-1418-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amorphous nanoparticles of curcumin (ANC) with primary particle sizes of 50 to 100 nm were prepared using a forced thin film reactor (FTFR). An ethanolic solution of curcumin and polyvinylpyrrolidone was mixed with purified water in an FTFR to precipitate the curcumin nanoparticles. In order to obtain amorphous particles, the solvent used and the operation conditions of FTFR such as the rotation speed of the disk and the flow rate of solutions were adjusted. According to powder X-ray diffraction (XRD) analysis and Fourier transform infrared spectroscopy (FT-IR), amorphous curcumin nanoparticles were obtained. To control the crystallinity, ultrasonic treatment was carried out on ANC suspended in water or hexane to which a polymer or a surfactant was added to prevent the growth of the particles. Transmission electron microscopy, XRD, and FT-IR analyses indicated that the treatment enabled the transformation of ANC to crystalline form 1 (a fundamental curcumin structure) and then to crystalline form 2 or crystalline form 3 without any change in the size of the primary particles. These findings suggest the possibility of preparing solid particles with a desired particle size and crystallinity.
引用
收藏
页数:9
相关论文
共 26 条
  • [1] Bioavailability of curcumin: Problems and promises
    Anand, Preetha
    Kunnumakkara, Ajaikumar B.
    Newman, Robert A.
    Aggarwal, Bharat B.
    [J]. MOLECULAR PHARMACEUTICS, 2007, 4 (06) : 807 - 818
  • [2] Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
    Blagden, N.
    de Matas, M.
    Gavan, P. T.
    York, P.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 617 - 630
  • [3] Cyclodextrins as pharmaccutical solubilizers
    Brewster, Marcus E.
    Loftsson, Thorsteinn
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 645 - 666
  • [4] Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
    de Waard, Hans
    Frijlink, Henderik W.
    Hinrichs, Wouter L. J.
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (05) : 1220 - 1223
  • [5] fda, OR BOOK APPR DRUG PR
  • [6] Micro reactors: principles and applications in organic synthesis
    Fletcher, PDI
    Haswell, SJ
    Pombo-Villar, E
    Warrington, BH
    Watts, P
    Wong, SYF
    Zhang, XL
    [J]. TETRAHEDRON, 2002, 58 (24) : 4735 - 4757
  • [7] Oral lipid-based formulations
    Hauss, David J.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 667 - 676
  • [8] Honda D, 2009, J JAP SOC COLOUR MAT, V82, P381, DOI [10.4011/shikizai.82.381, DOI 10.4011/SHIKIZAI.82.381]
  • [9] Honda D, 2009, J JAP SOC COLOUR MAT, V82, P284, DOI [10.4011/shikizai.82.284, DOI 10.4011/SHIKIZAI.82.284]
  • [10] Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs
    Jinno, J
    Kamada, N
    Miyake, M
    Yamada, K
    Mukai, T
    Odomi, M
    Toguchi, H
    Liversidge, GG
    Higaki, K
    Kimura, T
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) : 56 - 64